These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Completed, but no date||2014-000095-26||A randomised, parallel-group, open-label Phase II trial of the immunological effects of three regimens of GX301 vaccination in castration-resistant prostate cancer patients who have achieved response ...||bad-data|
|Ongoing||2016-005184-13||METRO STUDY - MESOGLYCAN VERSUS PLACEBO IN SECONDARY PREVENTION OF SURFACE VEIN THROMBOSIS STUDIO METRO - MESOGLICANO VERSUS PLACEBO NELLA PREVENZIONE SECONDARIA DELLA TROMBOSI VENOSA SUPERFICIALE||not-yet-due|